129 related articles for article (PubMed ID: 7515029)
1. Detection of the neural cell adhesion molecule (NCAM) in serum of patients with small-cell lung cancer (SCLC) with "limited" or "extensive" disease, and bone-marrow infiltration.
Ledermann JA; Pasini F; Olabiran Y; Pelosi G
Int J Cancer Suppl; 1994; 8():49-52. PubMed ID: 7515029
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of serum neural cell adhesion molecule as a new tumor marker in small cell lung cancer.
Jaques G; Auerbach B; Pritsch M; Wolf M; Madry N; Havemann K
Cancer; 1993 Jul; 72(2):418-25. PubMed ID: 8391379
[TBL] [Abstract][Full Text] [Related]
3. New serum markers for small-cell lung cancer. II. The neural cell adhesion molecule, NCAM.
Vangsted A; Drivsholm L; Andersen E; Bock E
Cancer Detect Prev; 1994; 18(4):291-8. PubMed ID: 7982239
[TBL] [Abstract][Full Text] [Related]
4. Serum neuron-specific enolase and immunohistochemical markers of neuroendocrine differentiation in lung cancer.
O'Shea P; Cassidy M; Freaney R; McCarthy P; Fennelly J
Ir J Med Sci; 1995 Jan; 164(1):31-6. PubMed ID: 7890531
[TBL] [Abstract][Full Text] [Related]
5. Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer.
Burghuber OC; Worofka B; Schernthaner G; Vetter N; Neumann M; Dudczak R; Kuzmits R
Cancer; 1990 Mar; 65(6):1386-90. PubMed ID: 2155054
[TBL] [Abstract][Full Text] [Related]
6. [The use of monoclonal antibodies that recognize the neural cell adhesion molecule (NCAM) in the diagnosis of bone marrow localization of small cell lung cancer].
Pasini F; Pelosi G; Santo A; Zaninelli M; Mostacci R; Masotti A; Spagnolli P; Recaldin E; Cetto GL
Minerva Med; 1994 Sep; 85(9):433-8. PubMed ID: 7936364
[TBL] [Abstract][Full Text] [Related]
7. Detection at diagnosis of tumor cells in bone marrow aspirates of patients with small-cell lung cancer (SCLC) and clinical correlations.
Pasini F; Pelosi G; Mostacci R; Santo A; Masotti A; Spagnolli P; Recaldin E; Cetto GL
Ann Oncol; 1995 Jan; 6(1):86-8. PubMed ID: 7536032
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody SEN7 recognizes a new epitope on the neural cell adhesion molecule present on small cell lung cancer but not on lymphocytes.
Waibel R; Mannhart M; O'Hara CJ; Brocklehurst C; Zangemeister-Wittke U; Schenker T; Lehmann HP; Weber E; Stahel RA
Cancer Res; 1993 Jun; 53(12):2840-5. PubMed ID: 7684948
[TBL] [Abstract][Full Text] [Related]
9. Enzyme-linked immunosorbent assay of pro-gastrin-releasing peptide for small cell lung cancer patients in comparison with neuron-specific enolase measurement.
Yamaguchi K; Aoyagi K; Urakami K; Fukutani T; Maki N; Yamamoto S; Otsubo K; Miyake Y; Kodama T
Jpn J Cancer Res; 1995 Jul; 86(7):698-705. PubMed ID: 7559089
[TBL] [Abstract][Full Text] [Related]
10. Detection of small-cell-lung-cancer cells in bone-marrow aspirates by monoclonal antibodies NCC-LU-243, NCC-LU-246 and MLuC1.
Pasini F; Pelosi G; Ledermann JA; Cetto GL
Int J Cancer Suppl; 1994; 8():53-6. PubMed ID: 8194897
[TBL] [Abstract][Full Text] [Related]
11. Characterization of tumor-associated neural cell adhesion molecule in human serum.
Takamatsu K; Auerbach B; Gerardy-Schahn R; Eckhardt M; Jaques G; Madry N
Cancer Res; 1994 May; 54(10):2598-603. PubMed ID: 7513253
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of neuron-specific enolase, carbohydrate antigen 19-9 and carbohydrate antigen 125 in carcinoma of the lung.
Oktay G; Güner G; Karlikaya C; Akkoçlu A
Biochem Soc Trans; 1995 May; 23(2):211S. PubMed ID: 7672232
[No Abstract] [Full Text] [Related]
13. Clinical applications of immunocytochemistry in the monitoring of the bone marrow in small cell lung cancer (SCLC).
Hay FG; Ford A; Leonard RC
Int J Cancer Suppl; 1988; 2():8-10. PubMed ID: 2832333
[TBL] [Abstract][Full Text] [Related]
14. Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC).
Shibayama T; Ueoka H; Nishii K; Kiura K; Tabata M; Miyatake K; Kitajima T; Harada M
Lung Cancer; 2001 Apr; 32(1):61-9. PubMed ID: 11282430
[TBL] [Abstract][Full Text] [Related]
15. The value of tumour markers in lung cancer.
Gomm SA; Keevil BG; Thatcher N; Hasleton PS; Swindell RS
Br J Cancer; 1988 Dec; 58(6):797-804. PubMed ID: 2906254
[TBL] [Abstract][Full Text] [Related]
16. Serum pseudouridine as a biochemical marker in small cell lung cancer.
Tamura S; Fujioka H; Nakano T; Hada T; Higashino K
Cancer Res; 1987 Nov; 47(22):6138-41. PubMed ID: 2822241
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution of a monoclonal antibody (RNL-1) against the neural cell adhesion molecule (NCAM) in athymic mice bearing human small-cell lung-cancer xenografts.
Boerman OC; Mijnheere EP; Broers JL; Vooijs GP; Ramaekers FC
Int J Cancer; 1991 May; 48(3):457-62. PubMed ID: 1645701
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow examination in small cell lung cancer--when is it indicated?
Feliu J; González Barón M; Artal A; Ordóñez A; Cebreiros I; Martín G; Garrido P; Chacón I; Montero García JM
Acta Oncol; 1991; 30(5):587-91. PubMed ID: 1654064
[TBL] [Abstract][Full Text] [Related]
19. An adherent subline of a unique small-cell lung cancer cell line downregulates antigens of the neural cell adhesion molecule.
Doyle LA; Borges M; Hussain A; Elias A; Tomiyasu T
J Clin Invest; 1990 Dec; 86(6):1848-54. PubMed ID: 1701450
[TBL] [Abstract][Full Text] [Related]
20. High tumour contamination of leukaphereses in patients with small cell carcinoma of the lung: a comparison of immunocytochemistry and RT-PCR.
Perey L; Benhattar J; Peters R; Jaunin P; Leyvraz S
Br J Cancer; 2001 Nov; 85(11):1713-21. PubMed ID: 11742493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
